Stereotactic Body Radiation Therapy for Low- and Low-Intermediate-Risk Prostate Cancer: Is there a Dose Effect?

@inproceedings{Katz2011StereotacticBR,
  title={Stereotactic Body Radiation Therapy for Low- and Low-Intermediate-Risk Prostate Cancer: Is there a Dose Effect?},
  author={Alan Jay Katz and Michael Santoro and Richard Ashley and Ferdinand Diblasio},
  booktitle={Front. Oncol.},
  year={2011}
}
This study examines the efficacy and toxicity of two stereotactic body radiation therapy (SBRT) dose regimens for treatment of early prostate cancer. Forty-one patients treated with 35 Gy were matched with 41 patients treated with 36.25 Gy. Both patient groups received SBRT in five fractions over five consecutive days using the CyberKnife. Each group had 37 low-risk patients and 4 intermediate-risk patients. No statistically significant differences were present for age, prostate volume, PSA… CONTINUE READING
2
Twitter Mentions

Citations

Publications citing this paper.
SHOWING 1-10 OF 15 CITATIONS

References

Publications referenced by this paper.
SHOWING 1-10 OF 50 REFERENCES

[Phase I dose-escalation study of stereotactic body radiation therapy for low- and intermediate-risk prostate cancer].

  • Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al]
  • 2012
VIEW 4 EXCERPTS
HIGHLY INFLUENTIAL

Stereotactic body radio

S. Jabbari, V. K. Weinberg, +9 authors A. R. Gottschalk
  • 2010
VIEW 7 EXCERPTS
HIGHLY INFLUENTIAL

Phase I dose-escalation study of stereotactic body radiation therapy for low- and intermediate-risk prostate cancer.

  • Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • 2011
VIEW 6 EXCERPTS
HIGHLY INFLUENTIAL

D.,and Mckellar,H

D. B. Fuller, G. Mardirossian, Wong
  • 2010
VIEW 5 EXCERPTS
HIGHLY INFLUENTIAL